Project: The impact of a motivational interviewing-based approach integrated with unique patient engagement technology on chronic pain management in a federally qualified health center.
Innovators: Aleda Chen, Pharm.D., Ph.D.; Marc Sweeney, PharmD, M.Div.; Phyllis Grauer, Pharm.D. (consultant); James Paat (InXite Health Systems); Ernest Boyd (Ohio Pharmacists Association)
Description: With rising rates of opioid misuse, there is a critical need to engage patients and healthcare providers in continuing to reduce the number of opioids prescribed for pain management. To address this, a provider training on motivational interviewing and pain management is incorporated into the care process. Providers then use motivational interviewing skills in patient care. Pharmacists and pharmacy interns also engage patients every few weeks to discuss and motivate patients in achieving pain management goals using a unique technology platform by InXite.
Project: Use of protein-based molecules including monoclonal antibodies aimed at promoting a balanced approach to blood vessel survival in patients with vascular impairments
Innovator: Rocco Rotello, Ph.D.
Description: Current therapies target unique vascular growth factor ligands through trapping or sequestering away from their native receptors, such as Eylea (Regeneron Pharmaceuticals), that binds vascular endothelial growth factor (VEGF) and reduce capillary leak in various eye disorders like age-related macular degeneration. The goal of these kinds of therapy is to reduce leaky vessels and promote stabilization and vessel intactness.
Project: Clinical pharmacist services in ambulatory care setting: Patients' and providers' satisfaction and impact on patient clinical outcomes
Innovator: Juanita Draime, Pharm.D.
Description: The long-term goal of this study is to support the continuing evolution of clinical pharmacist services. This project will assess both provider and patient satisfaction with clinical pharmacist services at a federally-qualified health center as well as assess if there is a correlation between patient satisfaction of clinical pharmacist services and patient clinical outcomes related to services provided (diabetes, hypertension, hyperlipidemia, and anticoagulation). This assessment will provide an evaluation of pharmacist services and allow for improvement and expansion of services to best serve the clinic needs.